You just read:

Health Canada Accepts Mitsubishi Tanabe Pharma Corporation's NDS Filing for Edaravone to Treat ALS, Grants Priority Review

News provided by

MitsubishiTanabe Pharma America

Apr 09, 2018, 14:00 ET